A modern phase 3 clinical trial suggests a more aggressive combination of therapies may lead to deeper remissions for patients facing a new diagnosis of multiple … Read more
For decades, the global approach to malnutrition was treated as a clinical puzzle to be solved with supplements, and calories. We focused on the “what”—the missing … Read more
For women facing advanced ovarian cancer, the path to recovery often begins with a high-stakes decision: whether to undergo major surgery first or start with chemotherapy … Read more
For decades, the medical community has understood that a person’s health is shaped by more than just their genetic code or the care they receive in … Read more
Health officials in the Republic of the Congo have confirmed the presence of a monkeypox virus lineage previously associated with West African outbreaks, marking a significant … Read more
For decades, the conversation around brain aging and dementia has been dominated by a single, daunting question: Is it in your genes? While hereditary markers like … Read more
For individuals grappling with obesity and related cardiovascular risks, a new analysis of the SELECT trial offers encouraging data regarding semaglutide, a medication already known for … Read more
The search for effective treatments for Alzheimer’s disease continues to face setbacks. Recent results from the large-scale, phase 3 EVOKE(+) trials indicate that semaglutide, a medication … Read more
The landscape of prenatal care may be on the cusp of a significant shift, offering new hope for families facing a diagnosis of myelomeningocele, a severe … Read more
